Notice of Changes to Funding Opportunities

• NIDCR Notice of Participation in PAR-20-076, "Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)"
  (NOT-DE-22-006)
  National Institute of Dental and Craniofacial Research
  

• Notice of Change to Expansion of Eligibility of PAR-21-336 (K12) Required Companion Application for CTSA Program Funding Opportunity PAR-21-293 (UM1)
  (NOT-TR-22-022)
  National Center for Advancing Translational Sciences
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed)
  (NOT-AI-22-032)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)
  (NOT-NS-22-083)
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  

• Notice of Intent to Publish a Funding Opportunity Announcement for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
  (NOT-TR-22-017)
  National Center for Advancing Translational Sciences
  

Notices of Special Interest

• Notice of Special Interest: Administrative Supplements for HIV/AIDS and Aging Research
  (NOT-AG-22-014)
  National Institute on Aging
  

• Notice of Special Interest (NOSI): Optimizing Vascularized Composite Allograft Survival
  (NOT-AI-22-023)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Special Interest (NOSI): CCRP Administrative Supplement for Collaborative Science to Synergize Chemical Medical Countermeasures Discovery and Early Development
  (NOT-AI-22-029)
  National Institute of Allergy and Infectious Diseases
  National Eye Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest (NOSI): Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supplements)
  (NOT-AT-22-010)
  National Center for Complementary and Integrative Health
  

• NOSI: Administrative Supplement for Global Integrative Oncology Research
  (NOT-CA-22-054)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Epidemiology of Drug Abuse
  (NOT-DA-22-004)
  National Institute on Drug Abuse
  

Funding Opportunities

• Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)
  (PAR-22-000)
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): May 30, 2024
  
  

• Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
  (PAR-22-089)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): May 07, 2025
  
  

• Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
  (PAR-22-114)
  National Cancer Institute
  Application Receipt Date(s): September 06, 2022; January 23, 2023; September 06, 2023; January 23, 2024; September 06, 2024; January 23, 2025 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional)
  (RFA-AG-23-007)
  National Institute on Aging
  Application Receipt Date(s): July 11, 2022
  
  

• Inter-Organelle Communication as a Platform to Interrogate the Interactions of Hallmarks of Aging (R01 Clinical Trial Not Allowed)
  (RFA-AG-23-012)
  National Institute on Aging
  Application Receipt Date(s): October 11, 2022
  
  

• Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed)
  (RFA-AG-23-013)
  National Institute on Aging
  Application Receipt Date(s): October 11, 2022
  
  

• Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed)
  (RFA-AG-23-014)
  National Institute on Aging
  Application Receipt Date(s): July 01, 2022
  
  

• Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed)
  (RFA-AG-23-015)
  National Institute on Aging
  Application Receipt Date(s): October 11, 2022
  
  

• Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia (R01 Clinical Trial Not Allowed)
  (RFA-AI-22-010)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 01, 2022
  
  

• Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)
  (RFA-AI-22-012)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): July 01, 2022
  
  

• Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R01 - Clinical Trial Required)
  (RFA-DA-23-006)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R34 - Clinical Trial Required)
  (RFA-DA-23-007)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Renewal- Local Food Producer Outreach, Education, and Training to Enhance Food Safety and FDA Food Safety Modernization Act (FSMA) Compliance (U01) Clinical Trail Not Allowed
  (RFA-FD-22-024)
  Food and Drug Administration
  Application Receipt Date(s): April 29, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
  
  

• Renewal - Native American Tribes Outreach, Education, and Training to Enhance Food Safety and FSMA Compliance (U01) Clinical Trial Not Allowed
  (RFA-FD-22-025)
  Food and Drug Administration
  Application Receipt Date(s): April 29, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
  
  

• Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)
  (RFA-HL-23-018)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): December 10, 2024
  
  

• BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Human and Non-Human Primate Brain (UM1 Clinical Trial Not Allowed)
  (RFA-NS-22-047)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  Application Receipt Date(s): June 13, 2023
  
  

• BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Mouse Brain (UM1 Clinical Trial Not Allowed)
  (RFA-NS-22-048)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  Application Receipt Date(s): June 13, 2023
  
  

• BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
  (RFA-NS-22-049)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  Application Receipt Date(s): June 13, 2024
  
  

• Somatic Mosaicism across Human Tissues (SMaHT) Program: Organizational Center (U24 Clinical Trial Not Allowed)
  (RFA-RM-22-009)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): July 08, 2022
  
  

• Somatic Mosaicism across Human Tissues (SMaHT) Program: Data Analysis Center (UM1 Clinical Trial Not Allowed)
  (RFA-RM-22-010)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): July 08, 2022
  
  

• Somatic Mosaicism across Human Tissues (SMaHT) Program: Tool Development Projects (UG3/UH3 Clinical Trial Not Allowed)
  (RFA-RM-22-011)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): July 08, 2022
  
  

• Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (U24 Clinical Trial Not Allowed)
  (RFA-RM-22-012)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): July 08, 2022
  
  

• Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)
  (RFA-RM-22-013)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): July 08, 2022